Medical Weight Loss for Las Cruces, New Mexico Residents
Las Cruces, New Mexico residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.
Physician-supervised GLP-1 programs from $166/month · just $5.50/day, serving Las Cruces through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.
Why Las Cruces Residents Choose New Hope Weight Loss
Since 2020, New Hope Weight Loss has treated more than 5,400 patients from its Costa Mesa, California clinic, and Las Cruces, New Mexico residents get that same physician-led program by telehealth. Pricing is flat and transparent, with care overseen by Dr. Anjmun Sharma, M.D., and no insurance required to start.
Medical weight loss for Las Cruces is handled end-to-end online: intake, the $119 physician review with Dr. Sharma, dose titration, and follow-ups, all by secure video, with no drive and no pharmacy line.
Although our clinic is physically in Costa Mesa, California, Las Cruces residents receive the same physician-supervised care without leaving New Mexico. We care for patients throughout Downtown, the Mesilla area, and the greater southern New Mexico region. Spanish-speaking Las Cruces patients complete the entire program, intake, consultation, and follow-up, in Spanish with our bilingual team.
For Las Cruces residents, being seen by video means starting this week instead of waiting for an in-person appointment. Compounded medication arrives in discreet, cold-pack packaging at your Las Cruces address, usually within days.
GLP-1 Weight Loss Programs Available
Semaglutide (90-Day Metabolic Reset), from $166/mo
Our most popular program for Las Cruces patients uses semaglutide, the same active ingredient found in Wegovy® and Ozempic®. In clinical trials of the branded drug, patients lost an average of 15-17% of body weight, with physician oversight and monthly dose adjustments.
Tirzepatide (Advanced Program), from $233/mo · just $7.70/day
For maximum results, tirzepatide uses a dual GLP-1/GIP mechanism that clinical trials showed can reach up to 22.5% body-weight loss.
Doctor review: $119. Medication billed separately. HSA, FSA, Klarna, and Affirm accepted.
How Telehealth Works for Las Cruces
1. Tell us your history through the quiz or intake form. 2. Dr. Sharma confirms your eligibility by secure video, usually within 48 hours. 3. Your compounded medication arrives at your Las Cruces address in cold-pack packaging, with ongoing follow-up from the team, all without leaving home.
Frequently Asked Questions, Las Cruces
Does New Hope Weight Loss treat patients in Las Cruces?
Yes. Although the clinic is in Costa Mesa, California, we treat Las Cruces, New Mexico residents by telehealth, Dr. Sharma reviews your case by secure video and compounded medication ships to your home. Eligibility is confirmed during the consultation.
Do I have to travel to get started from Las Cruces?
No travel is needed. The whole process, intake, consultation, and follow-ups, is by secure video, and your medication arrives at your Las Cruces address in cold-pack packaging.
What do Las Cruces patients pay?
Flat nationwide pricing: $119 for the physician review, then semaglutide from $166/month and tirzepatide from $233/month, medication billed separately. HSA, FSA, Klarna, and Affirm are accepted, with no distance surcharge.
What areas of Las Cruces do you serve?
We serve patients from across Las Cruces by telehealth, including Downtown, the Mesilla area, and the greater southern New Mexico region.
How is medication shipped to Las Cruces patients?
After Dr. Sharma approves your plan, compounded medication ships in discreet, temperature-appropriate packaging directly to your Las Cruces address from the identified 503(a) compounding pharmacy. Most patients receive it within days, with no pharmacy line and no drive.
New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Las Cruces, New Mexico by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.